ArticleNPJ Parkinson's disease2026
Shared gene signatures and biochemical regulatory networks linking Parkinson's disease and ulcerative colitis.
Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epidemiological studies suggest an association between Parkinson's disease (PD) and ulcerative colitis (UC), yet the molecular programs potentially linking these disorders remain poorly defined. Here, we integrated curated disease-gene resources with publicly available blood transcriptomic datasets to identify shared molecular features across PD and UC. We identified 320 shared signature genes and a topology-derived 10-gene core module that included TNF, IL1B, TP53, BCL2, and CASP3. Enrichment analyses implicated a convergent inflammatory-stress architecture characterized by microbial-response, oxidative-stress, lipid/inflammatory, and IL-17-related signaling programs. Immune deconvolution revealed partially overlapping peripheral immune alterations in PD and UC, most notably reduced memory B-cell abundance. Network analyses further highlighted TP53 and JUN as major transcriptional hubs and prioritized several candidate compounds for follow-up investigation. Cross-validation and external validation showed that only a subset of the core genes retained stable discriminatory performance across cohorts, indicating that network centrality did not uniformly translate into robust classifier-like behavior. Collectively, these findings support a shared inflammatory/apoptotic regulatory module linking PD and UC and provide a systems-level framework for mechanistic studies and therapeutic prioritization, rather than a definitive biomarker panel.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.